138163-12-9 Usage
General Description
1-Cbz-4-methylene-piperidine is a chemical compound with the molecular formula C14H21NO. It is a piperidine derivative with a Cbz (carboxybenzyl) protecting group and a methylene group (CH2) attached to the fourth position of the piperidine ring. 1-Cbz-4-methylene-piperidine has potential applications in organic synthesis and pharmaceutical research, as it can be used as a building block for the synthesis of other organic compounds. It may also have biological activity and could be studied for potential therapeutic uses. The specific properties and uses of 1-Cbz-4-methylene-piperidine may vary depending on the context of its application in research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 138163-12-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,1,6 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 138163-12:
(8*1)+(7*3)+(6*8)+(5*1)+(4*6)+(3*3)+(2*1)+(1*2)=119
119 % 10 = 9
So 138163-12-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H17NO2/c1-12-7-9-15(10-8-12)14(16)17-11-13-5-3-2-4-6-13/h2-6H,1,7-11H2
138163-12-9Relevant articles and documents
PYRIMIDINE SULFAMIDE DERIVATIVE AND PREPARATION METHOD AND MEDICAL APPLICATION THEREOF
-
Paragraph 0252-0254, (2020/09/22)
Disclosed are a series of pyrimidine sulfamide compounds and applications thereof in preparing a drug for a disease related to an ETA receptor antagonist. In particular, disclosed is a derived compound represented by formula (I) or a tautomer or pharmaceutically acceptable composition thereof.
Compound as potassium channel modulator
-
Paragraph 1053; 1055; 1056; 1057, (2018/07/30)
The invention relates to a compound as a potassium channel modulator, which is a compound of a formula (I) or a pharmaceutically acceptable salt thereof. The compound or the pharmaceutically acceptable salt thereof is effective for curing and preventing diseases and symptoms influenced by the activity of potassium ion channels.
NRF2 REGULATORS
-
Page/Page column 121, (2017/01/02)
Provided are aryl analogs，pharmaceutical compositions containing them and their use as NRF2 regulators.
